Individual Study / The Janus Serum Biobank

The Janus Serum Biobank

The Janus Serum Biobank

The Janus Serum Biobank logo
Initiatives -
To make the material available to cancer researchers over the whole world, and deliver quality assured samples and data. **General Contact:janus@kreftregisteret.no**
Start Year
1973
End Year
2004
Funding
Initial funding for the sample collection to the Janus cohort was provided by the Norwegian Cancer Society. The Cancer Registry of Norway has funded the biobank operation since 2004.
Supplementary Information
https://academic.oup.com/ije/article/46/2/403/2617162; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108113/
Visit The Janus Serum Biobank

Members

Download
Investigators Contacts
  • Dr Hilde Langseth
    Cancer Registry of Norway
  • Dr Randi Gislefoss (Quality manager):
    Cancer Registry of Norway

Design

Study design
Population cohort
Follow Up
The Janus cohort members have been followed up from the date they donated the first serum sample until the date of cancer diagnosis, emigration or death.
Supplementary Information
https://pubmed.ncbi.nlm.nih.gov/27063606/

Marker Paper

Langseth H, Gislefoss RE, Martinsen JI, Dillner J, Ursin G. Cohort Profile: The Janus Serum Bank Cohort in Norway. Int J Epidemiol. 2017 Apr 1;46(2):403-404g. doi: 10.1093/ije/dyw027.

PUBMED 27063606

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
316,951
Number of participants with biosamples
Supplementary Information
165.390 men; 151.561 women

Access

Availability of data and biosamples

Data
Biosamples
Other

Availability of access information

On the study website : https://www.kreftregisteret.no/en/Research/Janu...